The wide currency and weak credit logic may continue, and the upward direction of the market volatility will not change. The Shanghai and Shenzhen 300ETF South (159925) is gaining momentum. On December 11, the Shanghai and Shenzhen 300ETF South (159925) closed down by 0.25%, with a turnover of 75,892,100 yuan. The constituent stocks are mixed. In terms of rising, Midea Group led the rise, and Changjiang Power followed suit. In terms of decline, China Ping An led the decline, while Contemporary Amperex Technology Co., Limited followed. In the news, Contemporary Amperex Technology Co., Limited, the power battery giant, once again announced that it will build a power battery factory overseas, which will also become the company's third battery factory in Europe. Bank of China Securities said that the important meeting at the end of the year is about to land, and the market may face fluctuations caused by the expected landing of policies in the short term, but the tone of monetary policy will not change. The logic of "wide money+weak credit" will continue in the short term. Under the expectation of loose monetary policy, the upward direction of market volatility will not change. According to industry insiders, looking forward to 2025, the allocation of A-share industry can be developed around three main lines: first, the direction of domestic macro-circulation, attaching importance to "duality and innovation", "debt conversion" and new growth points in the consumption field; Second, science and technology are self-reliant: pay attention to artificial intelligence industry, self-controllable, new energy technology, aerospace information technology and data elements; The third is to open wider to the outside world: pay attention to cross-border e-commerce, digital trade, tax exemption and inbound tourism. You can use the Shanghai and Shenzhen 300ETF South (159925) to lay out the core assets with one click.On the 11th, alumina fell by 3.61%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract alumina 2502 closed, with a volume of 174,600 lots. The position data showed that the top 20 seats were net, and the difference position was 10,936 lots. The total turnover of alumina futures contracts was 452,500 lots, an increase of 77,000 lots over the previous day. The first 20 seats in the contract held 264,800 lots, a decrease of 4,558 lots from the previous day. The short positions in the top 20 seats of the contract were 215,500 lots, a decrease of 1,290 lots from the previous day. (Sina Futures)Zhewen Internet: Zhejiang Internet (600986) announced on the evening of December 11th that the company intends to authorize the management of the company to make an independent decision to dispose of the stock of Doushen Education Technology (Beijing) Co., Ltd. (hereinafter referred to as "Doushen Education") held by the company through centralized bidding or block trading. The authorization period is within 36 months from the date of deliberation and approval by the shareholders' meeting. As of the date of announcement, the company holds 61.06 million shares of Doushen Education, accounting for 2.95% of the total share capital of Doushen Education, and will lift the restriction on sales on December 29, 2024.
The Ukrainian military said it attacked the oil depot in the Bryansk region of Russia.CLP Xingfa: At present, the company is not involved in quantum technology or application. CLP Xingfa said on the interactive platform on December 11 that the company is not involved in quantum technology or application at present.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.
KBW upgraded Societe Generale to outperform the broader market with a target price of 32 euros.Yao Anna became the brand ambassador of Baique Ling, and Baique Ling officially announced Yao Anna as the brand ambassador on December 11th.Kyle Rodda, a financial market analyst in Capital.com, looks forward to the US CPI in November: The expected CPI data basically gives the Fed a green light to cut interest rates next week, which may be the gold catalyst we need to see.
Strategy guide 12-14
Strategy guide
Strategy guide
12-14